Increased risk of mental health problems after cancer during adolescence : A register-based cohort study

© 2020 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC..

In this nationwide, register-based study, we estimated the risk of mental health problems in 2822 individuals diagnosed with cancer in adolescence (13-19 years). Mental health problems were assessed by psychiatric diagnoses and/or prescribed psychotropic drugs. Cox proportional hazards models estimated hazard ratio (HR) for a psychiatric diagnosis and prescription of psychotropic drug compared to a matched comparison group (n = 28 220). Estimates were adjusted for calendar period and parent characteristics (eg, history of psychiatric diagnosis, education, country of birth). We found an increased risk of a psychiatric diagnosis during the first 5 years after the cancer diagnosis (females: HR 1.23, 95% CI, 1.06-1.44; males: HR 1.32, 95% CI, 1.11-1.56), and at >5 years after diagnosis (females: HR 1.31, 95% CI, 1.09-1.58, males: HR 1.45, 95% CI, 1.18-1.77). The risk of being prescribed antidepressant (females: HR 1.54, 95% CI, 1.30-1.84, males: HR 2.06, 95% CI, 1.66-2.55), antipsychotic (females: HR 2.28, 95% CI, 1.56-3.34, males: HR 3.07, 95% CI, 2.13-4.42), anxiolytic (females: HR 1.95, 95% CI, 1.64-2.31, males: HR 4.02, 95% CI, 3.34-4.84) and sedative drugs (females: HR 2.24, 95% CI, 1.84-2.72, males: HR 3.91, 95% CI, 3.23-4.73) were higher than for comparisons during the first 5 years after diagnosis. Median age at first psychiatric diagnosis and first prescribed psychotropic drug were 18 years. In conclusion, cancer during adolescence is associated with increased risk of mental health problems that may develop in close proximity to treatment. The findings emphasize the need for comprehensive care during treatment and follow-up.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:147

Enthalten in:

International journal of cancer - 147(2020), 12 vom: 15. Dez., Seite 3349-3360

Sprache:

Englisch

Beteiligte Personen:

Hovén, Emma [VerfasserIn]
Ljung, Rickard [VerfasserIn]
Ljungman, Gustaf [VerfasserIn]
Ljungman, Lisa [VerfasserIn]
Skoglund, Charlotte [VerfasserIn]
Fransson, Emma [VerfasserIn]
Wikman, Anna [VerfasserIn]

Links:

Volltext

Themen:

Adolescence
Anti-Anxiety Agents
Antidepressive Agents
Antipsychotic Agents
Cancer
Journal Article
Mental health problems
Psychiatric diagnoses
Psychotropic drugs
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 16.04.2021

Date Revised 16.04.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/ijc.33154

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM311150489